EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Adverse Effects Associated with the Newer Inotropic Agents

M W Webster, D N Sharpe

Medical Toxicology · 1986

DOI: 10.1007/bf03259847 ↗

At a glance

Übersichtsarbeit in Medical Toxicology, 1986. Written by M W Webster and 1 co-authors. Cited 9 times so far (Crossref); 49 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The ideal inotropic agent should be available for both parenteral and oral administration and be potent and effective long term without significant adverse effects. In recent years, numerous new agents have been developed in an attempt to find a more potent, less toxic alternative to digoxin. beta-Agonists, while useful when given parenterally short term, appear to have their long term oral application limited by adverse effects and the development of tolerance. A number of other non-catecholamine agents, most of which have both inotropic and vasodilator actions, have also been studied. Adverse effects have been relatively frequent and occasionally severe. Of these newer agents none has yet been proven in clinical trials to be safe and effective in the long term.

Subjects

MeSH terms (MEDLINE)

Adrenergic beta-AgonistsCardiotonic AgentsHumansPhosphodiesterase InhibitorsVasodilator Agents

Substances

Adrenergic beta-AgonistsCardiotonic AgentsPhosphodiesterase InhibitorsVasodilator Agents

Cite

APA

Webster, M. W., & Sharpe, D. N. (1986). Adverse Effects Associated with the Newer Inotropic Agents. Medical Toxicology. https://doi.org/10.1007/bf03259847

Vancouver

Webster MW, Sharpe DN. Adverse Effects Associated with the Newer Inotropic Agents. Medical Toxicology. 1986. doi:10.1007/bf03259847

BibTeX
@article{Webster1986,
  author = {Webster, M W and Sharpe, D N},
  title = {Adverse Effects Associated with the Newer Inotropic Agents},
  journal = {Medical Toxicology},
  year = {1986},
  doi = {10.1007/bf03259847}
}
Start for free →